BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
iShares MSCI Switzerland ETF
EWL
$1.32B
| $910K | ﹤0.01% |
19,795
+18,913
| +2,144% | +$869K |
|
2002
TEGNA Inc
TGNA
$3.39B
| $910K | ﹤0.01% |
49,738
+10,700
| +27% | +$196K |
|
|
HUYA
2003
Huya Inc
HUYA
$749M
| $909K | ﹤0.01% |
295,933
+91,387
| +45% | +$281K |
|
|
BOW
2004
Bowhead Specialty Holdings
BOW
$964M
| $904K | ﹤0.01% |
25,443
+8,169
| +47% | +$290K |
|
2005
SpartanNash
SPTN
$897M
| $902K | ﹤0.01% |
49,252
-13,128
| -21% | -$241K |
|
2006
Pearson
PSO
$9.05B
| $899K | ﹤0.01% |
+55,764
| New | +$899K |
|
2007
Light & Wonder
LNW
$7.45B
| $897K | ﹤0.01% |
10,386
-2,048
| -16% | -$177K |
|
2008
Fulgent Genetics
FLGT
$672M
| $896K | ﹤0.01% |
48,527
+4,714
| +11% | +$87.1K |
|
2009
Artivion
AORT
$1.87B
| $895K | ﹤0.01% |
31,298
+2,724
| +10% | +$77.9K |
|
2010
Tandem Diabetes Care
TNDM
$840M
| $894K | ﹤0.01% |
24,819
-268,768
| -92% | -$9.68M |
|
2011
iShares US Energy ETF
IYE
$1.16B
| $892K | ﹤0.01% |
19,571
-4,957
| -20% | -$226K |
|
2012
Karyopharm Therapeutics
KPTI
$54.3M
| $889K | ﹤0.01% |
87,593
-44,564
| -34% | -$452K |
|
2013
AppFolio
APPF
$9.9B
| $887K | ﹤0.01% |
3,597
-2,336
| -39% | -$576K |
|
2014
Edgewise Therapeutics
EWTX
$1.48B
| $883K | ﹤0.01% |
+33,082
| New | +$883K |
|
2015
Genpact
G
$7.2B
| $883K | ﹤0.01% |
20,560
-27,397
| -57% | -$1.18M |
|
2016
Sinclair Inc
SBGI
$971M
| $881K | ﹤0.01% |
+54,589
| New | +$881K |
|
|
TIGR
2017
UP Fintech Holding
TIGR
$1.93B
| $880K | ﹤0.01% |
136,290
+132,846
| +3,857% | +$858K |
|
2018
Independence Realty Trust
IRT
$3.96B
| $880K | ﹤0.01% |
44,348
-10,754
| -20% | -$213K |
|
2019
Federated Hermes
FHI
$4.09B
| $879K | ﹤0.01% |
21,393
-48,596
| -69% | -$2M |
|
2020
Lifestance Health
LFST
$2.03B
| $876K | ﹤0.01% |
+118,842
| New | +$876K |
|
|
TXNM
2021
TXNM Energy, Inc.
TXNM
$5.97B
| $874K | ﹤0.01% |
17,778
-7,015
| -28% | -$345K |
|
2022
Avient
AVNT
$3.27B
| $872K | ﹤0.01% |
+21,338
| New | +$872K |
|
|
SII
2023
Sprott
SII
$1.8B
| $869K | ﹤0.01% |
+20,611
| New | +$869K |
|
2024
Douglas Emmett
DEI
$2.74B
| $868K | ﹤0.01% |
46,748
-9,626
| -17% | -$179K |
|
2025
Ameris Bancorp
ABCB
$5.06B
| $860K | ﹤0.01% |
13,737
-9,044
| -40% | -$566K |
|